Advaxis, Inc. Made Headway
Mon 10 Feb 20 at 05:41 PM
Advaxis, Inc. (ADXS:NASDAQ) soared at $1.07, representing a gain of 28.7%. The stock got featured on our News Catalysts scanner on Thu 30 Jan 20 at 10:31 AM in the 'BIOTECH' category. From Fri 17 Jan 20, the stock recorded 14.29% Up Days and 20.00% Green Days
The stock spiked on Tue 07 Jan 20 at $1.48 with a volume of 39M+.
About Advaxis, Inc. (ADXS:NASDAQ)
Advaxis Inc focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies.
Top 10 Gainers:
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 1335.24%
- Precigen, Inc. (XON:NYSE), 293.2%
- Precigen, Inc. (XON:NASDAQ), 293.2%
- Taubman Centers, Inc. (TCO:NYSE), 53.22%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 52.38%
- Youdao, Inc. (DAO:NYSE), 39.48%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 34.58%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 32%
- Advaxis, Inc. (ADXS:NASDAQ), 28.71%
- Edgewell Personal Care Company (EPC:NYSE), 27.53%